Advertisement
Screener

BIO-TECHNE Corp (TECH) Net Margin

BIO-TECHNE Corp (TECH) Net Margin

  • 2026-06-30: Net Margin 17.01%.
  • 2026-03-31: Net Margin 16.39%.
  • 2025-12-31: Net Margin 12.85%.
  • 2025-09-30: Net Margin 13.33%.

Complete source-backed net margin history.

Available history
2009-06-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3017.01%
2026-03-3116.39%
2025-12-3112.85%
2025-09-3013.33%
2025-06-30-5.58%
2025-03-317.14%
2024-12-3111.75%
2024-09-3011.61%
2024-06-3013.26%
2024-03-3116.17%
2023-12-3110.08%
2023-09-3018.41%
2023-06-3025.05%
2023-03-3123.87%
2022-12-3118.41%
2022-09-3033.21%
2022-06-3021.35%
2022-03-3120.92%
2021-12-3129.77%
2021-09-3027.01%
2021-06-305.78%
2021-03-3118.80%
2020-12-3120.63%
2020-09-3016.35%
2020-06-3033.47%
2020-03-3118.71%
2019-12-3164.68%
2019-09-307.86%
2019-06-308.59%
2019-03-3124.16%
2018-12-3110.06%
2018-09-3010.68%
2018-06-3023.13%
2018-03-3112.04%
2017-12-3131.69%
2017-09-3010.97%
2017-06-3017.63%
2017-03-3115.39%
2016-12-315.67%
2016-09-3014.43%
2016-06-3019.02%
2016-03-3123.13%
2015-12-3121.38%
2015-09-3020.21%
2015-06-3022.38%
2015-03-3121.28%
2014-12-3129.66%
2014-09-3022.04%
2014-06-3028.99%
2014-03-3133.11%
2013-12-3129.82%
2013-09-3032.02%
2013-06-3035.75%
2013-03-3140.89%
2012-12-3133.78%
2012-09-3034.21%
2012-06-3034.62%
2012-03-3137.98%
2011-12-3134.57%
2011-09-3035.47%
2011-06-3036.30%
2011-03-3140.73%
2010-12-3139.19%
2010-09-3038.82%
2010-06-3038.81%
2010-03-3146.09%
2009-12-3137.73%
2009-09-3040.24%

Annual Net Margin

DateNet Margin
2026-06-3014.97%
2025-06-306.02%
2024-06-3014.50%
2023-06-3025.10%
2022-06-3024.61%
2021-06-3015.08%
2020-06-3031.04%
2019-06-3013.46%
2018-06-3019.62%
2017-06-3013.51%
2016-06-3020.94%
2015-06-3023.82%
2014-06-3031.01%
2013-06-3036.24%
2012-06-3035.71%
2011-06-3038.73%
2010-06-3040.80%
2009-06-3039.87%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Twist Bioscience Corp (TWST)United States$11.540B-47.21
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78